Lung Function

Race-specific vs. race-neutral lung function equations misclassified more patients with pulmonary fibrosis eligible for trials, therapy and transplantation referral, according to results published in Annals of the American Thoracic Society.

WASHINGTON — Showing more improvement in bronchodilator responsiveness testing was linked to more exacerbations, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Over time, reductions in lung function following exposure to World Trade Center dust heighten the risk for all-cause and cancer-cause mortality, according to results published in Annals of the American Thoracic Society.

Among patients with idiopathic pulmonary fibrosis, higher microbial diversity in the mouth negatively impacted lung function, according to results published in American Journal of Respiratory and Critical Care Medicine.

Both a chronic productive cough and an intermittent productive cough were linked to poor lung function trajectories spanning from childhood to adulthood, according to study results published in The Lancet Respiratory Medicine.

Adolescents with greater amounts of abdominal fat depots compared with their peers also had reduced lung function, regardless of previous adiposity or BMI, according to a study published in Pediatric Allergy and Immunology.

Patients with moderate to severe type 2 asthma, poor asthma control and high sleep disturbance experienced fewer nighttime symptoms and exacerbations with dupilumab, according to results published in Respiratory Medicine.

In patients with pulmonary fibrosis, consuming omega-3 fatty acids may improve diffusing capacity for carbon monoxide and lengthen survival, according to results published in CHEST.

Among adolescents, increases in average rain or snowfall over a week resulted in heightened fractional exhaled nitric oxide, signaling airway inflammation, according to results published in Annals of the American Thoracic Society.

Topline results from a phase 2b trial revealed that rademikibart led to improvements in lung function and asthma control in adults with moderate to severe persistent asthma compared with placebo.